BACKGROUND: Anti-obesity effects of calcium antagonists such as benidipine and nifedipine have been described in rodent obesity models, but the mode of action of the calcium antagonists as anti-obesity agents has not been established. OBJECTIVE: To examine whether the anti-obesity effects of calcium antagonists (here benidipine) could be ascribed to a direct stimulation of brown adipose tissue (BAT) thermogenesis. METHODS: Examination of the ability of benidipine to induce thermogenesis (increased rate of oxygen consumption) in isolated brown-fat cells from rats, mice and hamsters -and in intact cold-acclimated rats. RESULTS: Benidipine itself, or in combination with any dose of noradrenaline (NA), was totally unable to induce or augment thermogenesis in isolated brown-fat cells of any species tested. However, it markedly induced thermogenesis in intact animals (approx 60% increase over resting metabolic rate). This effect could be fully inhibited by propranolol. CONCLUSION: Benidipine is itself without thermogenic effect. The thermogenic response in-vivo (and thus presumably the anti-obesity effect) is probably secondary to a previously described general side-effect of calcium antagonists: a release of NA from sympathetic nerves, here most likely directly from nerves in the BAT. The antiobesity effect of benedipine is thus probably not due to its calcium channel blocking effect. PERSPECTIVES: It is probable that the anti-obesity effects of calcium antagonists reported in several models of genetically obese rodents (MSG-obese and agouti mice, SHHFaMcc-fa cp and JCR:LA-corpulent rats) are mediated via an indirect stimulation of BAT. To what extent calcium antagonists may induce similar effects in a clinical situation, is currently unknown.
Introduction
Calcium antagonists (calcium channel blockers) are generally thought to exert their therapeutic action by inhibiting L-type calcium channels in the heart and especially in the peripheral vascular system. 1 This leads to decreased vascular resistance, and these agents are thus clinically used for treatment of hypertension and other cardiovascular diseases. 2 However, apparently unrelated anti-obesity effects of chronic treatment of rodents with calcium antagonists, have been reported: the calcium antagonist benidipine has an anti-obesity effect in MSG-obese mice 3 and, similarly, the calcium antagonist nifedipine is an anti-obesity agent in agouti-obese mice 4 and in different strains of corpulent rats. 5, 6 An explanation of these anti-obesity effects has not been given, but concerning the effect of benidipine in MSG-obese mice, there are indications that the effects of this agent may be linked to brown adipose tissue (BAT), the activity of which is diminished in these mice 7 : chronic treatment of these mice with benidipine results in recruitment of BAT, that is, an increase in tissue mitochondrial content and in the content of the uncoupling protein (UCP1) and thus probably in total thermogenic capacity. 3 Furthermore, benidipine acutely stimulates blood¯ow to BAT in rats. 8 However, the observations of effects of a calcium antagonist on BAT are confounding. This is because both the acute thermogenic process and the process of recruitment of the tissue, 9, 10 are mediated via adrenergic receptors which in physiological contexts are stimulated by noradrenaline (NA), released from the sympathetic nerves innervating the tissue. There is thus no direct conceptual linkage between calcium antagonists and BAT activation. Several explanations for the apparent but unexpected stimulatory effects of calcium antagonists on BAT may be suggested. One would be that these agents could also be weak adrenergic agonists which, at high concentrations, could elicit thermogenesis and tissue recruitment through the conventional adrenergic receptors. Another explanation would be that these agents could interact with non-adrenergic receptors that could be able to induce thermogenesis.
We have therefore examined the ability of the calcium antagonist benidipine to induce thermogenesis in brown-fat cells and in intact animals. We ®nd that benidipine is devoid of direct thermogenic effects in brown-fat cells, but can elicit thermogenesis in intact animals, apparently in an indirect way.
Materials and methods

Animals
The hamsters (from the institute colony), rats (Sprague-Dawley from B&K Universal AB, Stockholm, Sweden) and mice (NMRI from B&K), used for the preparation of isolated brown-fat cells, were adult male animals that had been living at 20 ± 22 C with free access to water and food (rat and mouse standard diet (B&K) for the rats and mice; a mixture of sunower seeds, rabbit chow (K5, Lactamin, Vadstena, Sweden), dry carrots, oats and wheat sprouts for the hamsters). For the studies of metabolic rate in intact animals, 12-week old rats of the Sprague-Dawley strain, obtained from Eklunds (Stockholm, Sweden) were acclimated for six weeks at 4 C with free access to food (as above) and water, before the experiments shown here; where indicated, rats reared under normal control conditions, as above, were used.
Thermogenesis in isolated brown-fat cells
Brown-fat cells were isolated, as earlier described, by collagenase digestion of pooled BAT depots. 11 Thermogenesis (the rate of oxygen consumption) was followed in an oxygen electrode chamber at 37 C; a KrebsaRinger bicarbonate buffer was used.
11 NA (Arterenol, bitartrate salt, Sigma, Stockholm, Sweden) was freshly dissolved in water and benidipine hydrochloride was dissolved in 95% ethanol, which was subsequently diluted in 0.5% Tween-80 (Kebo-Lab, Stockholm, Sweden) in saline to give a 10 mM stock solution with 34% ethanol, or it was freshly prepared as a 10 mM solution in 95% ethanol (further diluted with ethanol as necessary), or in DMSO (Sigma), as indicated.
Metabolic rate of intact animals
The metabolic rate of intact rats was followed in an open-circuit metabolic chamber, principally as earlier described. 12 In some rats, the heart rate was simultaneously followed; for this purpose, these rats were ®rst brie¯y sedated with avertin (tribromoethyl alcohol (Aldrich, Stockholm, Sweden) tertiary amyl alcohol (Fluka, Stockholm, Sweden), i.p. injection as a 2.5% solution, 5 ml per g body weight) in order to place an MLT1010 pulse transducer from ADInstruments (Hastings, UK) around the chest. The output signal from this transducer was collected via an ADInstruments Maclaba2e to an Iomega Zip 100 disk drive and ®nally analysed (that is, derivated, smoothed and baseline-tracked before ratemeter analysis) on a Macintosh with the Chart application from ADInstruments. The rats (some of which thus equipped with the pulse transducer) were placed individually in the metabolic chamber, which had a temperature of 28 C. The chamber temperature and the metabolic rate (oxygen consumption rate) of the rats were continuously monitored. After 30 ± 60 min, the rats were injected i. 
Results
Investigation of the effect of benidipine on isolated mature brown-fat cells
As the acute effect of benidipine on blood¯ow to BAT had been observed in intact rats, 8 we here ®rst examined whether a direct thermogenic effect of benidipine on brown-fat cells isolated from this species could be observed. In Figure 1 , a typical experiment is depicted. As seen in trace A, the brown-fat cells initially utilized oxygen at a low basal rate. Addition of the vehicle (Veh), to be used for benidi- Figure 1 Absence of thermogenic effect of benidipine in isolated brown-fat cells. Isolated brown-fat cells from rats acclimated to 21 C were incubated in KrebsaRinger bicarbonate buffer. In trace A, the cells were ®rst treated with 10 ml 34% ethanol in 0.5% Tween-80 in saline (that is, the vehicle for benidipine) (Veh), and 5 min later, 1 mM noradrenaline (NA) (dissolved in water) was added. In trace B, 100 mM benidipine (Ben) dissolved in the above vehicle was ®rst added, and then NA as before.
Calcium antagonists and thermogenesis J Zhao et al pine, had no effect on this basal thermogenic rate. The further addition of the endogenous inducer of thermogenesis, NA, led, as expected, to a marked increase in thermogenic rate. When benidipine was added instead of the vehicle (trace B), no effect different from that of the solvent itself was observed. Furthermore, when NA was added after benidipine, it was still able to elicit a thermogenic response, at a level practically identical to that observed after solvent addition. Thus, no direct thermogenic effect of benidipine could be observed in isolated brown adipocytes.
Benidipine is not readily soluble, and the absence of effect of benidipine could thus be due to a nonoptimal solvent being used. We therefore repeated the experiment in Figure 1 with benidipine dissolved in ethanol or in DMSO. No differences were observed, except that the ethanol itself tended to lead to a small increase in the basal rate. Thus, no effect of benidipine, in excess of that of the vehicle, could be seen in either case (not shown).
It was also possible that benidipine could be selfinhibitory at the high concentration used (100 mM), and we therefore performed dose-response experiments, varying the benidipine concentration from 10 nM to 100 mM. However, no dose tested induced a thermogenic response (not shown). Thus, brown-fat cells isolated from rats seemed thermogenically insensitive to benidipine.
The acute BAT response to benidipine earlier observed in the rat was, however, only an increase in blood¯ow. 8 This may thus only have been a circulatory effect and does not necessarily represent a true thermogenic activation of the tissue in this animal. In contrast, in the mouse, a clear recruiting effect of chronic benidipine treatment on brown adipose tissue has been observed. 3 It might therefore be so that the absence of effect of benidipine on isolated brown-fat cells could be speci®c to the rat species. We accordingly repeated the above experiments with brown-fat cells isolated from mice. The results were the same as with brown-fat cells from rats: there was no thermogenic effect of benidipine (not shown). We further tested preparations of brownfat cells from hamsters, with the same negative result (not shown).
Thus, despite a variety of conditions (solvents, concentration range) and animals being tested, we could ®nd no evidence that benidipine in itself possessed thermogenic action.
However, benidipine could be suggested to interact with endogenous NA under in vivo conditions, namely that the cells in the animals may be in a state of continuous slight stimulation with NA, and benidipine could perhaps augment the stimulatory effect of such a marginal NA stimulation. We therefore tested whether the presence of benidipine increased the sensitivity of isolated rat brown-fat cells to NA. As seen in Figure 2 , this was not the case: there was clearly no positive interacting effect of benidipine on the NA-induced thermogenesis; if anything, there was a tendency to a slight reduction in the maximal rate of the NA-induced thermogenesis.
We also performed this type of experiment with brown-fat cells isolated from mice and hamsters and obtained results very similar to those shown in Figure  2 (not shown).
Thus, in the in vitro systems investigated here, we were unable to observe any indication that benidipine itself, or in combination with NA, was able to induce or augment thermogenesis in brown-fat cells.
Thermogenic effect of benidipine in vivo
To our knowledge, no study of the ability of benidipine (or of any other calcium antagonist) to induce an acute thermogenic response in intact animals has as yet been published. The blood¯ow effects of acute benidipine treatment 8 -and to a certain extent also the recruitment effects of chronic benidipine treatment 3 -would a priori imply that benidipine was thermogenic, but the absence of a thermogenic effect for benidipine on isolated brown-fat cells demonstrated above, and the non-adrenergic structure of the substance itself, made it necessary to clarify this issue.
We therefore examined whether a thermogenic effect of benidipine could be observed in intact animals. For this study, we again chose to investigate the response of rats, as the acute effect of benidipine on blood¯ow to BAT was demonstrated in this species. 8 To facilitate the observation of thermogenic effects of benidipine, we ®rst examined the effect of benidipine in cold-acclimated rats which have a large thermogenic capacity, due to their recruited BAT. 9 As seen in the exempli®ed experiment in Figure  3A , in the metabolic chamber with an ambient temperature of 28 C, the rat examined here initially had a . An injection of NA -at a dose earlier established 13 to yield a maximal thermogenic response from BAT -led, as expected, to a large (2 ± 3-fold) increase in oxygen consumption (thermogenesis) ( Figure 3A ). In the experiment illustrated in Figure 3A , this response lasted for 82 min and a total of 1044 ml O 2 per kg 0.75 was consumed as an effect of the NA injection. When the resting metabolic rate (RMR) had been regained, the rat was injected with the vehicle. A metabolic response to this injection was observable, but this response was small and short-lasting (24 min, corresponding to 43 ml O 2 per kg 0.75 ) and involved a burst of physical activity. After about one further hour, benidipine was injected. Unexpectedly, this substance, which was totally without thermogenic effect in isolated brown-fat cells ( Figure 1 and Figure 2) , was indeed able to induce a thermogenic response corresponding in this animal to maximally an approx 50% increase in metabolic rate.
The response was long-lasting (112 min), and a total of 443 ml O 2 per kg 0.75 was consumed during the response to benidipine. Thus, the effect of this dose of benidipine was at least 10-fold higher than that of the vehicle alone and approached half of the response to NA.
In Figure 3B , we investigated whether the response to benidipine was secondary to benidipine being injected after NA; as seen, this was not the case.
In Figure 4 , we have compiled data from a series of experiments in which the responses to benidipine, vehicle alone and noradrenaline were measured. As expected for all mammals, the mean resting metabolic rate was close to 11 ml O 2 per min per kg 0.75 . Benidipine led to a signi®cant increase in metabolic rate, maximally 52% above basal. The response to benidipine had a mean duration of 84AE 17 min, that is, signi®cantly longer than that of vehicle alone (25 AE 1; P`0.01), and at least as long as that seen after NA injection (70 AE 5 min).
To examine whether benidipine, in addition to the unexpected thermogenic effect, also induced the expected circulatory effects, we followed the heart rate of some rats during this type of experiment. Although this was technically dif®cult in these unrestrained non-anaesthetized animalsÐand the values obtained thus would be somewhat uncertainÐrates of approx 370 bpm in the basal state before NA addition and approx 570 bpm during the maximal thermogenic response to NA were estimated, in Figure 3 Effect of benidipine on metabolic rate of cold-acclimated rats. A. A cold-acclimated rat was placed in the metabolic chamber. The rat remained undisturbed in the chamber for about 1 h, and the recordings shown here started approx 20 min before the indicated i.p. injection (NA) of 1 mg NA bitartrate per kg body weight (corresponding to 3.1 mmolakg). Vehicle indicates injection of 0.8 ml of the mixture of saline, ethanol and Tween-80, used as solvent for both NA and benidipine (see Methods). Benidipine indicates an injection of 0.85 mg benidipine hydrochloride (corresponding to 1.6 mmolakg). The injection artefacts result from the inlet of air into the system during the injections. B. The experiment was performed (on another rat) principally as in A but with benidipine being the ®rst injected compound. RMR resting metabolic rate. Figure 4 Mean maximal metabolic responses in cold-acclimated rats. The data are from eight experiments performed as those in Figure 3 , that is, the three agents were injected in different order (to eliminate any effect of injection order; however, no such effect was observable). The mean weight of the rats was 312 AE 19 g. Resting metabolic rate (RMR) was de®ned as the lowest rate consistently maintained for 4 min, and the maximal metabolic rate after each injection was determined as that above which the response was maintained for at least 4 min. agreement with earlier observations. 14, 15 During the maximal thermogenic response to benidipine, a heart rate of only approx 250 was estimated. This bradycardic effect of benidipine is in agreement with earlier observations in non-cold-acclimated rats. 8 However, it is surprising that it is possible, with such a low heart rate, to sustain the substantially increased rate of thermogenesis observed after benidipine injection in these cold-acclimated rats; this would indicate an increase in stroke volume, perhaps combined with a redistribution of cardiac output.
If the thermogenic response to benidipine was mediated by BAT, it would be expected that the magnitude of the response should be in¯uenced by the acclimation temperature of the rats studied. Therefore we also examined the ability of rats living under control conditions (that is, at 20 ± 22 C) to respond thermogenically to benidipine. Such an experiment is exempli®ed in Figure 5 . As also seen in this rat, the response to benidipine was higher than that to the vehicle alone. This experiment was performed totally in 5 rats, with alternating injections schemes vehicleabenidipine. The mean increase in metabolic rate over basal in the 60 min after benidipine injection was 152AE 4 ml O 2 per kg 0.75 , whereas the corresponding value after vehicle injection was only 99 AE 16 ml (P`0.01; Student's paired t-test; rat body weight 291AE 20 g). Thus a response to benidipine was also found in rats living at normal animal house temperature. The response was, however, lower than that observed in cold-acclimated rats, as expected if it is through activation of BAT that the benidipine-induced thermogenesis occurs. (In these rats, the response to NA was only 379AE 23 ml O 2 Á kg 70.75 during the 60 min after injection.)
Thus, when given to intact rats, benidipine demonstrated the expected effects on a cardiovascular parameter but, unexpectedly with reference to the in vitro data shown above, it also had a clear thermogenic effect, probably mediated through activation of BAT.
Effect of b-adrenergic blockade on benidipine-induced thermogenesis
There could be several explanations for the thermogenic effect of benidipine in vivo, despite the absence of such an effect in vitro. One could be that during the isolation process, the brown-fat cells could have lost an unknown non-b-adrenergic receptor type, which would mediate the benidipine effect in vivo. Another possibility could be that in the animal, the injection of benidipine could lead to a release of NA from the nerve endings in the tissue, and it would be this NA that caused the thermogenic response. Such an effect has earlier been observed for other substances. 16 In order to investigate which of these possibilities was the more likely, we examined whether the thermogenic response to benidipine was adrenergically mediated. This was done by inhibiting the b-receptors of the tissue with the classical b-blocker propranolol. As the thermogenic response is mainly mediated via b 3 -adrenergic receptors which have a comparatively low sensitivity to propranolol, 17 a rather high dose of propranolol is needed. We have earlier found it necessary to use 20 mg D,L-propranolol per kg body weight, for inhibition of the cold-induced, b 3 -receptor Figure 5 Effect of benipine injection on the metabolic rate of a rat acclimated to normal animal house temperature (20 ± 22 C). The experiment was performed principally as that described in Figure 3 , on a rat with a body weight of 233 g. The rat was ®rst injected with benidipine and then with vehicle. Results from a series of such experiments, with alternating order of injection, are given in the text. RMR resting metabolic rate. Figure 6 Effects of propranolol on the metabolic response to benidipine in cold-acclimated rats. A. The experiment was performed principally as that in Figure 3 , but the rat was ®rst injected with 20 mgakg D,L-propranolol (pro) and 15 min later, benidipine (ben) was injected as before. The following day, after 24 h at 21 C, the rat was again returned to the cold room, and a further 8 d later, its ability to respond to benidipine was again tested (trace B). In C, mean maximal metabolic rates from ®ve experiments as that in A is compiled, and in D, correspondingly from B. ## indicates a signi®cant difference between the benidipine-induced mean maximal metabolic rates elicited directly or after propranolol preinjection (P`0.01; Student's paired t-test). RMR resting metabolic rate. 18 and this dose has also been found to be suf®cient to inhibit thermogenesis induced by different agents, the thermogenic effect of which is supposed to be mediated via a centrally controlled release of NA in the tissue. 19 ± 21 As expected, the injection of propranolol had in itself no effect on the RMR ( Figure 6A ). However, after propranolol injection, benidipine lost its ability to induce thermogenesis. Thus, the thermogenic effect of benidipine in the intact rat, was probably due to a release of endogenous NA from the nerves within the BAT and was thus indirectly mediated through badrenergic receptors. We ®nally tested whether the rats could regain their ability to respond thermogenically to benidipine in the absence of propranolol. As seen in Figure 6B , this was clearly the case: benidipine, when injected alone, led to a thermogenic response which here approached a doubling of the RMR.
Calcium antagonists and thermogenesis
In Figure 6C ,D we have compiled a series of experiments performed as those exempli®ed in 6A, B. As shown, no statistically signi®cant increase in metabolic rate could be observed when benidipine was injected after propranolol ( Figure 6C ), but in the absence of propranolol, the effect of benidipine was very signi®cant (a mean increase over basal of 68%). The inhibitory effect of propranolol on the benidipine response was thus also very signi®cant (P`0.01).
Discussion
In the present investigation, we have found that the calcium antagonist benidipine was devoid of acute thermogenic effect, when examined in brown-fat cells in vitro. In contrast, benidipine was a competent inducer of thermogenesis in intact rats. This thermogenic effect was, however, fully eliminated when the rats were preinjected with the b-adrenergic blocker propranolol. Thus, the thermogenic effect of benidipine was probably secondary to a benidipine-induced release of NA, and it is likely that it was this endogenous NA that was the direct stimulator of thermogenesis. As the benidipine effect was larger in cold-acclimated, than in control, animals, the thermogenic effect was probably located to BAT. As delineated in Perspectives below, these observations may contribute to an understanding of the general anti-obesity effects of calcium antagonists.
Mechanism of action of benidipine and other calcium antagonists as indirect thermogenic agents
Benidipine is considered to exert its therapeutic effects by functioning as a calcium channel blocker. This effect is not easily connected with its ability to induce thermogenesis in vivo, which is demonstrated here to probably occur due to a release of NA within the BAT. Physiologically, the release of NA from sympathetic nerves is mediated via an increase in cytosolic calcium. No stimulatory effect of a calcium channel blocker on NA release would therefore be expected; rather, if anything, an inhibition of a physiologically stimulated release would be predicted. There is, however, established evidence from several laboratories that as an unexpected, and initially inexplicable, side (or even adverse) effect of calcium antagonists, noradrenaline release is induced in a wide variety of sympathetically innervated tissues, including the heart, aorta and other arteries, vas deferens, and the chromaf®n cells of the adrenal medulla. 22 ± 30 It has subsequently become clear that this release is caused by the calcium antagonists discharging the proton gradient that normally retains NA in the nerve vesicles. 29, 31 Thus, this leads to release of stored NA from the vesicles and, of course, to subsequent effects of this released NA, that is, in the present case an activation of BAT. BAT is indeed one of the tissues in which the highest concentrations of calcium antagonists are found, immediately after injection, 32 and it is thus most likely that the NA-releasing effect of benidipine occurs directly in the tissue ± although the present experiments cannot exclude the possibility that the benidipine effect is centrally mediated. However, in either view, the effect is clearly secondary to a NA release in the tissue and is not a direct benidipine effect on the brown-fat cells themselves.
Thus, the increased blood¯ow to BAT observed during benidipine infusion 8 probably does re¯ect an indirect metabolic activation of the tissue and not merely a vascular effect of the calcium antagonists. Similarly, chronic oral administration of benidipine 3 may lead to a chronic elevation of NA release, and this would then be causative of the BAT recruitment and of the anti-obesity effects of calcium antagonists in MSG-obese mice earlier reported. 3 
Perspectives
The present study is, as such, limited to the effect of one calcium antagonist (benidipine), but the results presented are probably of broader signi®cance, in that they introduce an alternative explanation for the antiobesity effects recurrently reported in different rodent systems of different calcium antagonists (since apparently all calcium antagonists induce release of NA from sympathetic nerve vesicles. 29, 31 ). We would here especially point to studies on the ameliorating effects of calcium antagonists on the obesity of agouti mice and on corpulent rats, and on possible clinical implications.
Calcium antagonists and obese agouti mice
Both the spontaneous agouti mutation and the transgenically induced agouti are obese. 33 The obesity in Calcium antagonists and thermogenesis J Zhao et al agouti mice is associated with ± and probably at least partly due to ± an atrophy of BAT; 34, 35 that is, there is a reduction of the content of the UCP1. Furthermore, the body temperature of the agouti mice is nearly 1 C lower than that of controls, in agreement with a reduced level of ongoing thermogenesis. 4 Chronic treatment of these mice with the calcium antagonist nifedipine ameliorates the obesity and increases the body temperature. 4 No direct explanation for this effect has so far been suggested, but based on the effects of calcium antagonists demonstrated here, a probable explanation for this effect of nifedipine treatment is that in these mice, just as in the MSGobese mice, 3 chronic calcium antagonist treatment leads to NA release through the mechanism described here and thus to BAT recruitment, with the expected effects on body weight and body temperature ± although such a recruiting effect on BAT in this particular system has not as yet been demonstrated. (Undoubtedly, in these mice, nifedipine also has its expected effects on calcium channels, probably including an inhibition of the agouti-protein-induced increases in cellular calcium levels, 36 but a re-activation of BAT thermogenesis would be a more direct and a more causative explanation for the anti-obesity effect.)
Anti-obesity effects of calcium antagonists in corpulent strains of rats
In two strains of corpulent rats ± the JCR:LA-corpulent rats 5 and the SHHFaMcc-fa cp rats 6 (which both incorporate the same corpulent (cp) gene) ± anti-obesity effects of a calcium antagonist have been reported. There is evidence that also cp-obesity is associated with and probably partly caused by an atrophied state of BAT. 37 In none of these strains is it known whether the calcium antagonist treatment leads to reactivation of BAT but this would be the predicted outcome based on the data presented here, and would explain the anti-obesity effects. The cp mutation probably occurs in the same gene as the fa (i.e. the leptin receptor) 38 and faafa rats would thus also be predicted to demonstrate an ameliorating effect of calcium antagonists on their obesity. However, again, all such effects may be considered trivial in the sense that they would probably occur through the calcium antagonist-induced NA release, reactivating the atrophied BAT and thus reducing obesity, and not be related to the orthodox calcium channel blocking activities of the calcium antagonist.
Clinical implications
b-Adrenergic blockers, a 1 -adrenergic blockers, ACE inhibitors and calcium antagonists (such as benidipine) are currently used classes of drugs against hypertension. Large population groups are therefore exposed to these types of drugs for extended periods of time. It is therefore of interest to discuss whether brown-fat-activating and anti-obesity effects of calcium antagonists, similar to those encountered in rodents, would be encountered in humans. That calcium antagonist treatment also leads to NA release in humans, is implied by the fact that not only infusion of calcium antagonists, 39 but also oral administration at clinically relevant doses, results in increased levels of NA in the plasma. 40 Whether this increase would be suf®cient to in¯uence the BAT depots in adult humans is not clear, but it is well documented that chronic high elevation of NA levels in the plasma also has this effect in adult humans. 41, 42 However, whether a recruited and activated BAT signi®cantly in¯uences obesity in adult humans is not as yet established.
It may be surmised that if the anti-obesity effect of calcium antagonists was of clinical signi®cance, this would have become evident during clinical trials. There is indeed one study that reports a small but statistically signi®cant effect of calcium antagonist treatment in this respect. 43 However, weight loss is generally recommended as part of the treatment for hypertension, and a decrease in body weight during calcium antagonist treament may therefore generally have been interpreted as a conscious slimming effort rather than being drug-induced. It may, however, be that what has been considered an adverse effect of calcium antagonist treatment, that is, NA release, may -by favouring a reduction in body weight -have at least one bene®cial effect in the treatment of hypertension.
